|
| 36890834 | Flavin fluorescence lifetime and autofluorescence optical redox ratio for improved visualization and classification of brain tumors. | Front Oncol | 2023 |
| 38024240 | Radiomic features define risk and are linked to DNA methylation attributes in primary CNS lymphoma. | Neurooncol Adv | 2023 |
| 37919354 | Multi-class glioma segmentation on real-world data with missing MRI sequences: comparison of three deep learning algorithms. | Sci Rep | 2023 |
| 37919325 | Segmentation of glioblastomas in early post-operative multi-modal MRI with deep neural networks. | Sci Rep | 2023 |
| 37915397 | Comparison of minimal detectable protoporphyrin IX concentrations with a loupe device and conventional 5-ALA fluorescence microscopy: an experimental study. | J Biomed Opt | 2023 |
| 37543970 | Mapping high-grade glioma immune infiltration to 5-ALA fluorescence levels: TCGA data computation, classical histology, and digital image analysis. | J Neurooncol | 2023 |
| 37390078 | Treatment of high-grade glioma patients during the COVID-19 pandemic: Impact on overall survival, tumor size and delay of treatment. | PLoS One | 2023 |
| 36947280 | Brain metastases from hepatopancreatobiliary malignancies. | Clin Exp Metastasis | 2023 |
| 35149260 | Analysis of corticosteroid and antiepileptic drug treatment effects on heme biosynthesis mRNA expression in lower-grade gliomas: Potential implications for 5-ALA metabolization. | Photodiagnosis Photodyn Ther | 2022 |
| 35766208 | Women in neurosurgery: review of the literature combined with a gender-based analysis of the development over the past 20 years in Austria. | J Neurosurg Sci | 2022 |
| 35430323 | Does pigmentation, hemosiderin and blood effect visible 5-ALA fluorescence in cerebral melanoma metastasis? | Photodiagnosis Photodyn Ther | 2022 |
| 35665365 | Heme Biosynthesis Factors and 5-ALA Induced Fluorescence: Analysis of mRNA and Protein Expression in Fluorescing and Non-fluorescing Gliomas. | Front Med (Lausanne) | 2022 |
| 35565293 | 7T HR FID-MRSI Compared to Amino Acid PET: Glutamine and Glycine as Promising Biomarkers in Brain Tumors. | Cancers (Basel) | 2022 |
| 35484633 | Fibroblast growth factor receptor 4 promotes glioblastoma progression: a central role of integrin-mediated cell invasiveness. | Acta Neuropathol Commun | 2022 |
| 36455278 | Toward digital histopathological assessment in surgery for central nervous system tumors using stimulated Raman histology. | Neurosurg Focus | 2022 |
| 35968292 | Preoperative Brain Tumor Imaging: Models and Software for Segmentation and Standardized Reporting. | Front Neurol | 2022 |
| 36187350 | The impact of heme biosynthesis regulation on glioma aggressiveness: Correlations with diagnostic molecular markers. | Front Mol Neurosci | 2022 |
| 36115057 | CD34 microvascularity in low-grade glioma: correlation with 5-aminolevulinic acid fluorescence and patient prognosis in a multicenter study at three specialized centers. | J Neurosurg | 2022 |
| 32608510 | High Diagnostic Accuracy of Visible 5-ALA Fluorescence in Meningioma Surgery According to Histopathological Analysis of Tumor Bulk and Peritumoral Tissue. | Lasers Surg Med | 2021 |
| 33546427 | Prognostic Value of 5-ALA Fluorescence, Tumor Cell Infiltration and Angiogenesis in the Peritumoral Brain Tissue of Brain Metastases. | Cancers (Basel) | 2021 |
| 33651248 | LAG-3 expression in the inflammatory microenvironment of glioma. | J Neurooncol | 2021 |
| 33540564 | Evaluation of the Temporal Muscle Thickness as an Independent Prognostic Biomarker in Patients with Primary Central Nervous System Lymphoma. | Cancers (Basel) | 2021 |
| 33562253 | Heme Biosynthesis mRNA Expression Signature: Towards a Novel Prognostic Biomarker in Patients with Diffusely Infiltrating Gliomas. | Cancers (Basel) | 2021 |
| 34885227 | Efficacy, Outcome, and Safety of Elderly Patients with Glioblastoma in the 5-ALA Era: Single Center Experience of More Than 10 Years. | Cancers (Basel) | 2021 |
| 34572900 | Glioblastoma Surgery Imaging-Reporting and Data System: Validation and Performance of the Automated Segmentation Task. | Cancers (Basel) | 2021 |
| 34395266 | 5-ALA in Suspected Low-Grade Gliomas: Current Role, Limitations, and New Approaches. | Front Oncol | 2021 |
| 34595120 | Fluorescence Lifetime Imaging and Spectroscopic Co-Validation for Protoporphyrin IX-Guided Tumor Visualization in Neurosurgery. | Front Oncol | 2021 |
| 34678775 | Influence of dexamethasone on visible 5-ALA fluorescence and quantitative protoporphyrin IX accumulation measured by fluorescence lifetime imaging in glioblastomas: is pretreatment obligatory before fluorescence-guided surgery? | J Neurosurg | 2021 |
| 34830859 | Reply to Stummer, W.; Thomas, C. Comment on "Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)-Experience at Two Specialized Centers. <i>Cancers</i> 2021, <i>13</i>, 2540". | Cancers (Basel) | 2021 |
| 33995593 | Favourable outcome of patients with breast cancer brain metastases treated with dual HER2 blockade of trastuzumab and pertuzumab. | Ther Adv Med Oncol | 2021 |
| 34187419 | Influence of preoperative corticosteroid treatment on rate of diagnostic surgeries in primary central nervous system lymphoma: a multicenter retrospective study. | BMC Cancer | 2021 |
| 34243150 | On the cutting edge of glioblastoma surgery: where neurosurgeons agree and disagree on surgical decisions. | J Neurosurg | 2021 |
| 34098230 | Primary tumor side is associated with prognosis of colorectal cancer patients with brain metastases. | ESMO Open | 2021 |
| 34064222 | 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)-Experience at Two Specialized Centers. | Cancers (Basel) | 2021 |
| 34209106 | PSMA Expression in 122 Treatment Naive Glioma Patients Related to Tumor Metabolism in <sup>11</sup>C-Methionine PET and Survival. | J Pers Med | 2021 |
| 34121071 | Androgen Receptor is Expressed in Breast Cancer Brain Metastases. | Appl Immunohistochem Mol Morphol | 2021 |
| 33956203 | Circulating PD-L1 levels change during bevacizumab-based treatment in recurrent glioma. | Cancer Immunol Immunother | 2021 |
| 34201021 | Glioblastoma Surgery Imaging-Reporting and Data System: Standardized Reporting of Tumor Volume, Location, and Resectability Based on Automated Segmentations. | Cancers (Basel) | 2021 |
| 34056605 | Timing of glioblastoma surgery and patient outcomes: a multicenter cohort study. | Neurooncol Adv | 2021 |
| 31049574 | Is Intraoperative Pathology Needed if 5-Aminolevulinic-Acid-Induced Tissue Fluorescence Is Found in Stereotactic Brain Tumor Biopsy? | Neurosurgery | 2020 |
| 33937837 | Robust Deep Learning-based Segmentation of Glioblastoma on Routine Clinical MRI Scans Using Sparsified Training. | Radiol Artif Intell | 2020 |
| 32045726 | Influence of Corticosteroids and Antiepileptic Drugs on Visible 5-Aminolevulinic Acid Fluorescence in a Series of Initially Suspected Low-Grade Gliomas Including World Health Organization Grade II, III, and IV Gliomas. | World Neurosurg | 2020 |
| 32096368 | Surgical microscope with integrated fluorescence lifetime imaging for 5-aminolevulinic acid fluorescence-guided neurosurgery. | J Biomed Opt | 2020 |
| 33110138 | Distributed changes of the functional connectome in patients with glioblastoma. | Sci Rep | 2020 |
| 33276339 | 5-ALA fluorescence for intraoperative visualization of spinal ependymal tumors and identification of unexpected residual tumor tissue: experience in 31 patients. | J Neurosurg Spine | 2020 |
| 33184096 | Soluble PD-L1 is associated with local and systemic inflammation markers in primary and secondary brain tumours. | ESMO Open | 2020 |
| 33235233 | Macroscopic fluorescence-lifetime imaging of NADH and protoporphyrin IX improves the detection and grading of 5-aminolevulinic acid-stained brain tumors. | Sci Rep | 2020 |
| 32977210 | High-resolution metabolic imaging of high-grade gliomas using 7T-CRT-FID-MRSI. | Neuroimage Clin | 2020 |
| 32730972 | Postoperative Magnetic Resonance Imaging After Surgery of Brain Metastases: Analysis of Extent of Resection and Potential Risk Factors for Incomplete Resection. | World Neurosurg | 2020 |
| 32722247 | TCGA mRNA Expression Analysis of the Heme Biosynthesis Pathway in Diffusely Infiltrating Gliomas: A Comparison of Typically 5-ALA Fluorescent and Non-Fluorescent Gliomas. | Cancers (Basel) | 2020 |